Filing Details

Accession Number:
0001639691-21-000052
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-20 20:01:52
Reporting Period:
2021-05-18
Accepted Time:
2021-05-20 20:01:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1639691 Livanova Plc LIVN Electromedical & Electrotherapeutic Apparatus (3845) 981268150
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1798597 Marco Dolci 20 Eastbourne Terrace
London X0 W26LG
Svp Global Operations, R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2021-05-18 7,259 $82.87 0 No 4 S Direct
Ordinary Shares Acquisiton 2021-05-18 3,926 $43.57 3,926 No 4 M Direct
Ordinary Shares Disposition 2021-05-18 2,907 $82.98 1,019 No 4 F Direct
Ordinary Shares Disposition 2021-05-18 1,019 $83.23 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Appreciation Rights Disposition 2021-05-18 3,926 $0.00 3,926 $43.57
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,777 No 4 M Direct
Footnotes
  1. Represents weighted average selling price. Securities sold through 34 separate sales on the transaction date at prices ranging from $82.31 to $83.21. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected.
  2. The referenced shares were withheld from distribution at the request of reporting person to satisfy tax liability and cost of option exercise.
  3. On March 30, 2020, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting schedule, the first vesting for which occurred on March 30, 2021. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the LivaNova Incentive Plan and the award agreement.
  4. This number reflects the number of derivative securities beneficially owned following reported transaction for this specific grant.